Addressing & Mitigating Gastrointestinal Toxicity in Claudin-Targeted Cancer Treatments
Time: 12:15 pm
day: Conference Day 1
Details:
- Investigating the gastrointestinal toxicity associated with claudin-targeted therapies, including mechanisms of toxicity and patient case studies
- Understanding strategies for managing and mitigating GI toxicity, such as dose adjustments, supportive care measures, and novel therapeutic approaches
- Exploring clinical trial designs aimed at reducing treatment-related GI toxicity, including the use of predictive biomarkers and early intervention strategies
